Outbreaks

Novavax vaccine 89% effective against COVID-19 in UK study, but less against South African variant; shares are rising

Novavax stock up more than 20% after COVID-19 vaccine trial shows nearly 90% efficacy in UK, but less against new South African variant

Novavax vaccine is 89% effective against Covid-19 in UK study

US economic growth slowed to 4% year-on-year at the end of 2020

Pfizer Covid-19 Vaccine Works Against Mutations Found in UK, South Africa Variants, Lab Study Finds

Trading Madness In AMC Stock May Prevent Bankruptcy, But Cinema Operator Still Faces Years Of Recovery

Africa, ill-equipped and without vaccines, is grappling with a more deadly Covid-19 spike

Shapeshifting virus threatens cycles of disease, blockages

Apple overtakes Amazon to become the world’s most valuable brand, while Tesla is growing the fastest

Does wearing two masks help prevent COVID-19 transmission? Dr. Fauci has an answer